2-phenethyl-5-phenyloxazole | 128488-64-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 2-phenethyl-5-phenyloxazole
• 英文别名: 5-Phenyl-2-(2-phenylethyl)-1,3-oxazole
• CAS: 128488-64-2
• 化学式: C₁₇H₁₅NO
• 分子量: 249.312
• InChiKey: UHGSONDNYMYPGW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.3
• 重原子数：
  19
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  26
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  2-氨基-1-苯乙醇 在 lithium diisopropyl amide 作用下， 反应 17.5h， 生成 2-phenethyl-5-phenyloxazole
  参考文献：
  名称：

  Lithiated 2-Methyl-5-Phenyloxizoles, Formation and Reactions with Electrophiles

  摘要：

  DOI：

  10.3987/com-89-s25

文献信息

• Synthesis of 2,5-disubstituted oxazoles <i>via</i> cobalt(<scp>iii</scp>)-catalyzed cross-coupling of <i>N</i>-pivaloyloxyamides and alkynes
  作者：Xiaolong Yu、Kehao Chen、Qi Wang、Wenjing Zhang、Jin Zhu

  DOI：10.1039/c7cc08611c

  日期：——

  An efficient synthesis of 2,5-disubstituted oxazoles via Co(III) catalysis is described herein. The synthesis is achieved under mild conditions through [3+2] cycloaddition of N-pivaloyloxyamides and alkynes. The reaction operates through an internal oxidation pathway and features a very broad substrate scope. The one-step synthesis of natural products such as texamine and balsoxin has been demonstrated

  本文描述了通过Co（III）催化的2，5-二取代的恶唑的有效合成。N-新戊酰氧基酰胺和炔烃的[3 + 2]环加成反应可在温和的条件下完成。该反应通过内部氧化途径进行，并且具有非常广泛的底物范围。通过该方案已证明了天然产品（如特克明和巴色辛）的一步合成。
• Synthesis of Oxazoles through Copper-Mediated Aerobic Oxidative Dehydrogenative Annulation and Oxygenation of Aldehydes and Amines
  作者：Zejun Xu、Chun Zhang、Ning Jiao

  DOI：10.1002/anie.201206382

  日期：2012.11.5

  A fragment‐assembling strategy is used to form oxazoles from aryl acetaldehydes, amines, and molecular oxygen under mild conditions (see scheme). The transformation is highly efficient with the removal of six hydrogen atoms, including the cleavage of four C(sp3)H bonds.

  片段组装策略用于在温和条件下由芳基乙醛，胺和分子氧形成恶唑（请参阅方案）。通过去除六个氢原子，包括四个C（sp 3）H键的裂解，该转化过程非常高效。
• THIAZOLE AND OXAZOLE KINASE INHIBITORS
  申请人：Moussy Alain

  公开号：US20130035331A1

  公开（公告）日：2013-02-07

  The present invention is concerned with substituted azole derivatives that selectively modulate, regulate, and/or inhibit signal transduction mediated by certain native and/or mutant proteine kinases implicated in a variety of human and animal diseases such as cell proliferative, metabolic, allergic, and degenerative disorders. In particular, several of these compounds are potent and selective Flt-3 inhibitors or/and syk inhibitors.

  本发明涉及替代咪唑衍生物，其选择性地调节、调控和/或抑制由某些天然和/或突变的蛋白激酶介导的信号转导，这些蛋白激酶涉及多种人类和动物疾病，如细胞增殖、代谢、过敏和退行性疾病。特别地，其中几种化合物是有效且选择性的Flt-3抑制剂或/和syk抑制剂。
• Metalation of Oxazole−Borane Complexes:  A Practical Solution to the Problem of Electrocyclic Ring Opening of 2-Lithiooxazoles
  作者：Edwin Vedejs、Sean D. Monahan

  DOI：10.1021/jo960813z

  日期：1996.1.1
• KASHIMA, CHOJI;ARAO, HIDEKI;OKADA, RIEKO, HETEROCYCLES, 30,(1990) N, C. 487-492
  作者：KASHIMA, CHOJI、ARAO, HIDEKI、OKADA, RIEKO

  DOI：——

  日期：——